Faraz Ali, Chief Executive Officer at Tenaya Therapeutics, Inc. (TNYA), sold 14,862 shares at $0.64 ($10K) on 2026-02-17, disclosed to the SEC on 2026-02-17.
Seasonal sale ($10k) by Chief Executive Officer — this insider has traded TNYA in February in at least three consecutive prior years. Pattern-driven, low signal.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $0.64 | 3,979 | $3K | 26.8% |
| 2 | $0.64 | 5,032 | $3K | 33.9% |
| 3 | $0.64 | 5,851 | $4K | 39.4% |
| Total | $0.64 avg | 14,862 | $10K | 100% |
| Filing → |
| TNYA | SELL | 2025-11-17 | $4K | — | Filing → |
| TNYA | SELL | 2025-08-18 | $18K | — | Filing → |
| TNYA | SELL | 2025-05-16 | $1K | — | Filing → |